Tag: neurological injury
RegeneRX receives Canadian patent for treating neurological injury and damage
RegeneRx Biopharmaceuticals has announced that the Canadian Patent Office has issued a Notice of Allowance for Thymosin beta 4 (Tβ4) for use in the treatment...